These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6480812)

  • 21. Origin and production rates of deoxycorticosterone and deoxycorticosterone sulfate in men and nonpregnant women.
    Casey ML; MacDonald PC
    J Clin Endocrinol Metab; 1983 Feb; 56(2):390-2. PubMed ID: 6822643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous prostacyclin synthesis is decreased during activation of the renin-angiotensin system in man.
    Watson ML; Goodman RP; Gill JR; Branch RA; Brash AR; Fitzgerald GA
    J Clin Endocrinol Metab; 1984 Feb; 58(2):304-8. PubMed ID: 6363436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship between electrolyte balance and the function of the renin- angiotensin-aldosterone system in fetuses and neonates (author's transl)].
    Yamaguchi N
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Dec; 33(12):2153-62. PubMed ID: 7040567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of 18-hydroxy-11-deoxycorticosterone secretion by angiotensin II and potassium.
    Moore TJ; Braley LM; Williams GH
    Endocrinology; 1978 Jul; 103(1):152-5. PubMed ID: 744066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deoxycorticosterone excretion in normal, hypertensive and hypokalaemic subjects.
    Cope CL; Loizou S
    Clin Sci Mol Med; 1975 Feb; 48(2):97-105. PubMed ID: 1167821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Origin of urinary nonconjugated 19-nor-deoxycorticosterone and metabolism of infused radiolabeled 19-nor-deoxycorticosterone in men and women.
    Casey ML; Guerami A; Milewich L; Gomez-Sanchez CE; MacDonald PC
    J Clin Invest; 1985 Apr; 75(4):1335-8. PubMed ID: 3988939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary free 18-hydroxy-11-desoxycorticosterone excretion in normal and hypertensive patients.
    Agrin RJ; Dale SL; Holbrook M; LaRossa JT; Melby JC
    J Clin Endocrinol Metab; 1978 Oct; 47(4):877-84. PubMed ID: 233684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered fractional tetrahydroaldosterone excretion during pharmacological blockade and activation of the renin-aldosterone system.
    Griffing GT; Wilson TE; Melby JC
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1217-21. PubMed ID: 6290525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prohormones in adrenal venous effluent in patients with primary hyperaldosteronism.
    Rao A; Melby JC; Wilson TE
    J Clin Endocrinol Metab; 1995 May; 80(5):1677-80. PubMed ID: 7745017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of 18-hydroxydeoxycorticosterone in the rat.
    Tan SY; Mulrow PJ
    Endocrinology; 1978 Apr; 102(4):1113-7. PubMed ID: 217614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bromocriptine does not inhibit the aldosterone response to sodium depletion.
    Carey RM; Van Loon GR
    J Clin Endocrinol Metab; 1982 Jul; 55(1):162-5. PubMed ID: 7042738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 19-nor-deoxycorticosterone excretion in rats bred for susceptibility and resistance to the hypertensive effects of salt.
    Dale SL; Holbrook MM; Melby JC
    Endocrinology; 1985 Dec; 117(6):2424-7. PubMed ID: 4065039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interaction of renin-angiotensin system inhibitors with dopamine in rat kidney].
    Kuz'min OB; Landar' LN; Buchneva NV
    Eksp Klin Farmakol; 2014; 77(7):16-9. PubMed ID: 25322648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women.
    Oelkers W; Berger V; Bolik A; Bähr V; Hazard B; Beier S; Elger W; Heithecker A
    J Clin Endocrinol Metab; 1991 Oct; 73(4):837-42. PubMed ID: 1890155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 19-Nor deoxycorticosterone (19-nor DOC): mineralocorticoid receptor affinity higher than aldosterone, electrolyte activity lower.
    Funder JW; Mercer J; Ingram B; Feldman D; Wynne K; Adam WR
    Endocrinology; 1978 Oct; 103(4):1514-7. PubMed ID: 744165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of aldosterone production in diuretic-induced hyperaldosteronism by aldosterone antagonist canrenone in man.
    Erbler HC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(4):395-401. PubMed ID: 4280522
    [No Abstract]   [Full Text] [Related]  

  • 38. Familiar hyperkalaemic acidosis.
    Licht JH; Amundson D; Hsueh WA; Lombardo JV
    Q J Med; 1985 Feb; 54(214):161-76. PubMed ID: 3885297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Renal effects of the acute inhibition of angiotensin-converting enzyme. I. 2) Studies during moderate potassium depletion].
    Agnoli GC; Borgatti R; Cacciari M; Ikonomu E; Lenzi P; Marinelli M; Martello M
    Boll Soc Ital Biol Sper; 1992; 68(8-9):561-6. PubMed ID: 1294206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response of several adrenal steroids to ACTH stimulation in essential hypertension.
    Honda M; Nowaczynski W; Guthrie GP; Messerli FH; Tolis G; Kuchel O; Genest J
    J Clin Endocrinol Metab; 1977 Feb; 44(2):264-72. PubMed ID: 190252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.